Gene Therapy: A Big Week for Many Names

A Barron’s cover story discussed a number of companies with potential in this exciting new field. But there’s other news, including strong clinical trial data from Alnylam and competing bids for Dimension Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.